��������

Jason Pontin joined the Strateos Board in 2021. He is a Partner at DCVC, where his belief that technology can solve big problems in health, sustainability, and industry informs his investments in life sciences and Deep Tech companies. He was the first investor in DCVC-backed Totus Medicines, where he is a founding board member, and in Menten.AI. Before joining DCVC, he was a senior partner and senior advisor at Flagship Pioneering in Cambridge, MA, where he worked with the enterprise’s therapeutics and agriculture companies. Jason was CEO and editor in chief of MIT Technology Review and editor of Red Herring magazine, the bible of the dot.com boom. At MIT, he founded MIT Solve, the Institute’s open innovation platform, which deploys capital and other resources toward solutions to grand challenges; chaired the MIT Enterprise Forum, the Institute’s global entrepreneurial community; and was senior advisor to MIT’s 16th President, Susan Hockfield. He has written for a range of publications including a column for the New York Times and articles for many other newspapers and magazines like The Economist, The Financial Times, The Boston Globe, and The Believer. He still writes, mostly for WIRED. At TED 2013, he delivered a Talk, “Can technology solve our big problems?” which has been seen 1.6 million times. Jason was raised in Berkeley and on a farm on the North Coast of California, where his family raised game birds for restaurants in the Bay Area. He was educated in the United Kingdom at Keble College, Oxford University, where he was awarded a B.A. and M.A in humanities fields completely unrelated to his investment interests.